Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...

MJH Life Sciences acquired BPD Healthcare, a 2025 MM+M Agency 100 honoree. Kenvue said it told the FDA its labeling request is unsupported by scientific evidence and would mark a departure from the ...

For the first nine months of 2025, Roche’s overall sales grew 7% at constant currencies to 45.9 billion Swiss francs (nearly ...

Iams, MD, MSCI, examined outcomes of the phase 3 IMforte trial in extensive-stage small cell lung cancer. Adding immunotherapy to platinum-based chemotherapy is an established standard of care for ...